ID: MRFR/CnM/1489-HCR | February 2021 | Region: Global | 100 pages
Biomaterials Market Size is anticipated to surpass of CAGR 7.80% by 2030, as reported in the latest study by Market Research Future.
List of Key Players in the Biomaterials Market
Some major players in the Biomaterials Market include
The Biomaterials Market is segmented on the basis of Type and Application.
On the basis of the Type, the Biomaterials Market is segmented into metallic, ceramics, polymeric, natural biomaterials, and others. The metallic segment is divided into stainless steel, titanium & titanium alloys, cobalt-chrome alloys, silver, gold, and magnesium. The ceramics segment is divided into calcium phosphate, aluminum oxide, zirconia, calcium sulfate, carbon, and glass. The polymeric segment is further divided into polymethylmethacrylate (PMMA), polyethylene, polyester, polyvinyl chloride, silicone rubber, nylon, polyetheretherketone (PEEK), polylactic acid, poly glycolic acid, and poly(lactide-coglycolide), and others. The natural biomaterials is further segmented into hyaluronic acid, collagen, gelatin, fibrin, cellulose, chitin, alginate, and silk
On the basis of the Application, the Biomaterials Market is classified into cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering, neurological disorders, and others
The cardiovascular segment is divided into catheters, stents, implantable cardiac defibrillators, pacemakers, sensors, heart valves, vascular grafts, guidewires, and others.
The orthopedic is divided into joint replacement, viscosupplementation, bioresorbable tissue fixation, spine, fracture fixation devices, and orthobiologics. The joint replacement is further divided into knee replacement, hip replacement, shoulder replacement, and others.
The bioresorbable tissue fixation is divided into suture anchors, interference screws, meniscal repair tacks, and meshes. The spine segment is divided into spinal fusion, minimally invasive fusion surgery, and motion preservation. The fracture fixation devices are divided into bone plates, screws, pins, rods, and wires.
The ophthalmology is further divided into contact lens, intraocular lens, functional replacements of ocular tissues, synthetic corneas, and others. The dental segment is further divided into dental implants, dental bone grafts & substitutes, dental membranes, and tissue regeneration materials. The plastic surgery is divided into soft tissue fillers and craniofacial surgery. The wound healing is categorized into wound closure devices, adhesion barriers, surgical hemostats, internal tissue sealants, and hernia meshes. The tissue engineering segment is divided into scaffolds for regenerative medicine, nanomaterials for biosensing, tailoring of inorganic nanoparticles. The neurological disorders segment is divided into shunting systems, cortical neural prosthetics, hydrogel scaffolds for CNS repair, neural stem cell encapsulation
Sources: Annual reports, Press release, White paper, and Company presentation
The Biomaterials Market consists of countries namely the Americas, Europe, Asia Pacific, and the Middle East.
The Americas dominate the Biomaterials Market owing to the increasing healthcare expenditure followed by Europe and Asia Pacific. According to the American Heart Association, the death due to cardiovascular diseases accounted for more than 800,000 in the U.S. Approximately 2,200 Americans die of cardiovascular disease each day. This increase in death ratio in North America is expected to drive the demand for biomaterials based cardiovascular systems. Europe holds the second position in the global biomaterials market owing to the government support for research & development and availability of funds for research.
Asia Pacific is the fastest growing region owing to the increasing obesity, introduction of biomaterials in cancer research, and rising patient awareness and improved lifestyle in growing economies such as India, China, and Brazil are expected to create opportunities in the biomaterials market. Additionally, the region has the highest potential to grow in the forecast period due to the presence of emerging economies such as China and India.
The Middle East & Africa holds the least share of the Biomaterials Market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa.
October 2021- Bucha Bio has sealed a round of funding with USD550,000 to support the company produce its bio textile solution a reality. The round has witnessed several VCs, including New Climate Ventures, Lifely, and MicroVentures, among several others, and angel investors Cary Pinkowski, Fiona and George Sobek, and Nicholas Valeriano. Moving from the round will aid Bucha to scale its flagship luxury bio textile, Mirai. It’s made from substantially renewable bacterial-nanocellulose and could relocate plastic-based and animal-based leathers.
In partnership with DuPont Biomaterials, October 2021- Part of Welspun Group, Welspun India has launched a latest home textile collection, including bed sheets and bath towels, made with bio-based materials to meet the increasing demand for sustainable home textile products. The partnerships get together cotton and DuPont Sorona fibers to make home textile fabrics. The fabrics utilized in the latest range offer a luxurious drape, moisture management, comfort, and a soft, smooth, and hand feel, stated both the companies in a joint press release.
July 13, 2019: In Spain, there will be a process of incorporating seven new biomaterials. In the latest, REGEMAT 3D will launch a catalog of biomaterials that customers can buy and use along with their bioprinting systems. In recent years, advances in 3D bioprinting systems have become very important, as well as new biomaterials for regenerative medicine.
December 2020: Zimmer Biomet Holdings, a renowned name in musculoskeletal healthcare, has announced that the company has accomplished the acquisition of A&E Medical Corporation, a prominent company manufacturing medical devices, for USD 15 million.
|Market Size||2030 : Significant value|
|Forecast Period||2020 to 2030|
|Historical Data||2019 & 2020|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||By Type, Application and Region|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), Covestro (Germany), Invibio Ltd. (U.K.), Carpenter Technology Corporation (U.S.), Evonik Industries AG (Germany), Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), and Celanese Corporation (U.S.), Wright Medical Technology, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bayer AG (Germany), Collagen Matrix (U.S.).|
|Key Market Opportunities||Increasing orthopedic disorders, and increasing funds by the government for research purposes.|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The biomaterials market would attain 7.80% CAGR between 2020 and 2030, the forecast period.
Factors like the rise in cardiovascular diseases, increasing wound healing therapies, booming geriatric population, surging demand for implantable devices, increasing awareness of regenerative medicine, superior properties of biomaterials, various orthopedic disorders, and increasing funds for R&D can influence the growth of the biomaterials market.
The Americas is slated to dominate the biomaterials market.
Prominent names to inspire influence in the biomaterials market are BASF SE (Germany), Royal DSM (Netherlands), Covestro (Germany), Corbion N.V. (Netherlands), Carpenter Technology Corporation (U.S.), Invibio Ltd. (U.K.), Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), Evonik Industries AG (Germany), Celanese Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bayer AG (Germany), Wright Medical Technology, Inc. (U.S.), Collagen Matrix (U.S.), and others.
Advertising, mergers, better R&D, product launch, collaborations, acquisitions, and other tactical changes are going to be implemented by the players involved in the biomaterials market.